کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2599973 | 1133244 | 2012 | 11 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: In vivo toxicological evaluation of Anisomycin In vivo toxicological evaluation of Anisomycin](/preview/png/2599973.png)
Anisomycin is a pyrrolidine antibiotic isolated from Streptomyces griseolus. Recent studies have shown that Anisomycin as a novel immunosuppressive agent is superior to Cyclosporine A (J. Immunother. 31, 858–870, 2008). In order to make toxicological evaluation of Anisomycin, acute and four-week continuously intravenous toxicity studies were performed in mice. IC50 value tested on peripheral lymphocytes was 25.44 ng/ml. The calculated LD50 for Anisomycin was 119.64 mg/kg. The mice were intravenously injected through mouse tail vein with a total dose of 5, 15, 30 and 60 mg/kg/mice of Anisomycin every other day for 4 weeks. Just in the high-dose mice, death of three mice happened and body weight of the mice was significantly decreased. Statistically significant changes in organ index included increases in ratios of the spleen, liver, lung and brain to the body weight, and decrease in ratio of the thymus to the body weight. Changes in clinical biochemistry parameters included increases in the aspartate aminotransferase (AST) and alanine aminotransferase (ALT) activities, and decreases in the glucose (GLU) activity. The distinct inflammation appeared in the lung, liver and kidney, and the number and size of megakaryocytes in the spleen were significantly increased. Anisomycin did not induce formation of the peripheral blood micronucleus, but increased the number of micronucleated polychromatic erythrocytes in bone marrow and sperm aberrations. However, the above aberrant changes occurred only in the mice treated with the high-dose Anisomycin. These results indicate that although Anisomycin has no significant side effects at effectively therapeutic doses, its over-dosage may lead to toxicity, particularly pulmo-, nephro- and hepato-toxicity.
► Anisomycin has no obviously in vivo side effects at effectively therapeutic doses (5–15 mg/kg).
► Over-dosage of it (60 mg/kg) may lead particularly to pulmo-, nephro- and hepato-toxicity.
► The IC50 of it on lymphocytes is 25.44 ng/ml and the LD50 on mice 119.64 mg/kg.
Journal: Toxicology Letters - Volume 208, Issue 1, 5 January 2012, Pages 1–11